Corlink long term follow up

From 2001 to 2004 the research department of cardiothoracic surgery
participated in the Multi-center trial Corlink. The study took place in our
center and in the Amphia Hospital Breda. In summary this was an experimental
trial to the applicability of adhesion-free connections in the coronary artery
surgery. One of the most important primary endpoints of this study was the
so-called short-term patency of coronary bypass grafts (patency = good blood
flow in the diversion). The study found that using a coronary angiogram. For
more details, I refer you to the Protocol to METC METC No # M00/1616 & M03/1359
#. At the time the study was successfully completed.

However, as already mentioned above, patients participated in an experimental
trial. Because we always strive for quality care, we believe that the
participants in this study are entitled to a long-term control.
Until recently it was not really possible without an invasive coronary
angiogram to do an audit of coronary bypass surgery. However, we recently have
this opportunity. This is today possible using the 256 multi-slice computed
tomography. For that reason we would then have patients who participated in the
study Corlink now want a quality offer.

The purpose of this audit is to demonstrate the long-term patency of Corlink
device compared to the standard "coronary artery bypass grafting (CABG). We
also offer this to patients in the study population an extra quality

We will we distill from our database, which patients in the study population
are still alive. These patients we through a letter or telephone call for
additional review. The audit will include an outpatient clinic where we visit a
short history and complete physical examination performed. In addition,
patients with written informed consent a CT scan of the heart undergo.

Minimal impact and risk.

Default risk due to contrast administration in CT scan.
Standard radiation exposure due to CT